Literature DB >> 26051203

Smoking-attributable medical expenditures by age, sex, and smoking status estimated using a relative risk approach.

Michael V Maciosek1, Xin Xu2, Amy L Butani3, Terry F Pechacek2.   

Abstract

OBJECTIVE: To accurately assess the benefits of tobacco control interventions and to better inform decision makers, knowledge of medical expenditures by age, gender, and smoking status is essential.
METHOD: We propose an approach to distribute smoking-attributable expenditures by age, gender, and cigarette smoking status to reflect the known risks of smoking. We distribute hospitalization days for smoking-attributable diseases according to relative risks of smoking-attributable mortality, and use the method to determine national estimates of smoking-attributable expenditures by age, sex, and cigarette smoking status. Sensitivity analyses explored assumptions of the method.
RESULTS: Both current and former smokers ages 75 and over have about 12 times the smoking-attributable expenditures of their current and former smoker counterparts 35-54years of age. Within each age group, the expenditures of formers smokers are about 70% lower than current smokers. In sensitivity analysis, these results were not robust to large changes to the relative risks of smoking-attributable mortality which were used in the calculations.
CONCLUSION: Sex- and age-group-specific smoking expenditures reflect observed disease risk differences between current and former cigarette smokers and indicate that about 70% of current smokers' excess medical care costs is preventable by quitting.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Health care costs; Health expenditures; Health expenditures/statistics & numerical data; Health services/utilization; Smoking; Smoking/economics; Tobacco

Mesh:

Year:  2015        PMID: 26051203      PMCID: PMC4597893          DOI: 10.1016/j.ypmed.2015.05.019

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  17 in total

Review 1.  Medical costs of smoking in the United States: estimates, their validity, and their implications.

Authors:  K E Warner; T A Hodgson; C E Carroll
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Smoking-attributable medical care costs in the USA.

Authors:  V P Miller; C Ernst; F Collin
Journal:  Soc Sci Med       Date:  1999-02       Impact factor: 4.634

3.  Changes in health care costs before and after smoking cessation.

Authors:  Paul A Fishman; Ella E Thompson; Elizabeth Merikle; Susan J Curry
Journal:  Nicotine Tob Res       Date:  2006-06       Impact factor: 4.244

Review 4.  Repeated tobacco-use screening and intervention in clinical practice: health impact and cost effectiveness.

Authors:  Leif I Solberg; Michael V Maciosek; Nichol M Edwards; Hema S Khanchandani; Michael J Goodman
Journal:  Am J Prev Med       Date:  2006-07       Impact factor: 5.043

5.  Healthcare costs around the time of smoking cessation.

Authors:  Jason M Hockenberry; Susan J Curry; Paul A Fishman; Timothy B Baker; David L Fraser; Ron A Cisler; Thomas C Jackson; Michael C Fiore
Journal:  Am J Prev Med       Date:  2012-06       Impact factor: 5.043

6.  Vital signs: current cigarette smoking among adults aged ≥18 years--United States, 2005-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-09-09       Impact factor: 17.586

7.  The risk of death by age, sex, and smoking status in the United States: putting health risks in context.

Authors:  Steven Woloshin; Lisa M Schwartz; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2008-06-10       Impact factor: 13.506

8.  Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-11-14       Impact factor: 17.586

9.  Reconciling medical expenditure estimates from the MEPS and NHEA, 2002.

Authors:  Merrile Sing; Jessica S Banthin; Thomas M Selden; Cathy A Cowan; Sean P Keehan
Journal:  Health Care Financ Rev       Date:  2006

10.  Tobacco product use among middle and high school students--United States, 2011 and 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-11-15       Impact factor: 17.586

View more
  10 in total

1.  Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students.

Authors:  Jonah Popp; John A Nyman; Xianghua Luo; Jill Bengtson; Katherine Lust; Lawrence An; Jasjit S Ahluwalia; Janet L Thomas
Journal:  Eur J Health Econ       Date:  2018-04-23

2.  Cost of Tobacco-related Cancer Hospitalizations in the U.S., 2014.

Authors:  Eric W Tai; Gery P Guy; C Brooke Steele; S Jane Henley; Michael S Gallaway; Lisa C Richardson
Journal:  Am J Prev Med       Date:  2018-02-01       Impact factor: 5.043

3.  A Cost-Effectiveness Analysis of Smoking-Cessation Interventions Prior to Posterolateral Lumbar Fusion.

Authors:  Thompson Zhuang; Seul Ku; Lauren M Shapiro; Serena S Hu; Akaila Cabell; Robin N Kamal
Journal:  J Bone Joint Surg Am       Date:  2020-12-02       Impact factor: 6.558

4.  Cigarette smoking in a Middle Eastern country and its association with hospitalisation use: a nationwide cross-sectional study.

Authors:  Abla Mehio Sibai; Mohamad Iskandarani; Andrea Darzi; Rima Nakkash; Shadi Saleh; Souha Fares; Nahla Hwalla
Journal:  BMJ Open       Date:  2016-04-08       Impact factor: 2.692

5.  Healthcare Costs of Smokers Using Varenicline Versus Nicotine-Replacement Therapy Patch in the United States: Evidence from Real-World Practice.

Authors:  Lauren J Lee; Qian Li; Marianna Bruno; Birol Emir; Brian Murphy; Surbhi Shah; Matthew Reynolds; Nick Marchant; Peter W Park
Journal:  Adv Ther       Date:  2018-12-19       Impact factor: 3.845

6.  Twenty-year health and economic impact of reducing cigarette use: Minnesota 1998-2017.

Authors:  Michael V Maciosek; Amy B LaFrance; Ann St Claire; Zack Xu; Morgan Brown; Barbara A Schillo
Journal:  Tob Control       Date:  2019-08-14       Impact factor: 7.552

7.  Effectiveness of Smoking Prevention Programs on the Knowledge, Attitudes, and Anti-Smoking Exposure Self-Efficacy among Non-Smoking Rural Seventh-Grade Students in Taiwan.

Authors:  Su-Er Guo; Mei-Yen Chen; Chizimuzo Okoli; Yi-Fan Chiang
Journal:  Int J Environ Res Public Health       Date:  2022-08-08       Impact factor: 4.614

8.  A cost-benefit analysis of smoking cessation prescription coverage from a US payer perspective.

Authors:  Christine L Baker; Yao Ding; Cheryl P Ferrufino; Stacey Kowal; Jenen Tan; Prasun Subedi
Journal:  Clinicoecon Outcomes Res       Date:  2018-07-16

9.  Smoking-Attributable Direct Healthcare Expenditure in Lithuania: A Prevalence-Based Annual Cost Approach.

Authors:  Vaida Liutkutė; Mindaugas Štelemėkas; Aurelijus Veryga
Journal:  Medicina (Kaunas)       Date:  2018-04-12       Impact factor: 2.430

10.  The 20-year impact of tobacco price and tobacco control expenditure increases in Minnesota, 1998-2017.

Authors:  Michael V Maciosek; Amy B LaFrance; Ann W St Claire; Paula A Keller; Zack Xu; Barbara A Schillo
Journal:  PLoS One       Date:  2020-03-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.